FCRL1 and multiple sclerosis: A comparative analysis of FCRL1 gene expression showed that the expression level of FCRL1 in PBMCs is significantly higher in patients with autoimmune diseases like multiple sclerosis, lupus anticoagulans, Takayasu's arteritis and also in von Willebrand disease as compared with the healthy controls.